{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:54:05Z","timestamp":1740174845165,"version":"3.37.3"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T00:00:00Z","timestamp":1626825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>While many studies have verified the effect of recent anti-cancer treatment in patients with COVID-19, there are no data on the optimal time for cancer treatment resumption, as well as the safety of chemotherapy in COVID-19 patients. As many cancer patients are recovering from COVID-19, there is an urgent need for reliable clinical information. Herein, we report a case of invasive ductal carcinoma in which we were able to successfully resume chemotherapy after infection with SAR-CoV-2.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>The patient was a 38-year-old non-smoking Japanese woman with no significant medical history. She had fever on days 5 and 6 of her second course of adjuvant FEC therapy, and on day 7, she tested positive for SARS-CoV-2 by RT-PCR. She was hospitalized for 11\u00a0days. We resumed the therapy on day 25 after discharge, as she had no remaining clinical symptoms. The patient completed four courses of the initial chemotherapy without any major adverse events nor the recurrence of COVID-19, and subsequently completed four courses of docetaxel as her second regimen therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Evaluating the risk for each patient is essential when resuming anti-cancer therapy in cancer patient\u2019s post-COVID-19.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40792-021-01253-0","type":"journal-article","created":{"date-parts":[[2021,7,21]],"date-time":"2021-07-21T13:05:38Z","timestamp":1626872738000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Chemotherapy resumption in breast cancer patient after COVID-19"],"prefix":"10.1186","volume":"7","author":[{"given":"Julian","family":"Horiguchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2443-6995","authenticated-orcid":false,"given":"Ayako","family":"Nakashoji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Matsui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takayuki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,7,21]]},"reference":[{"key":"1253_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S1470-2045(20)30217-5","volume":"21","author":"TK Burki","year":"2020","unstructured":"Burki TK. Cancer guidelines during the COVID-19 pandemic. Lancet Oncol. 2020;21:629\u201330.","journal-title":"Lancet Oncol"},{"key":"1253_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.breast.2020.04.006","volume":"52","author":"G Curigliano","year":"2020","unstructured":"Curigliano G, Cardoso MJ, Poortmans P, Gentilini O, Pravettoni G, Mazzocco K, et al. Recommendations for triage, prioritization and treatment of breast cancer patients during the COVID-19 pandemic. Breast. 2020;52:8\u201316.","journal-title":"Breast"},{"key":"1253_CR3","doi-asserted-by":"publisher","first-page":"3538","DOI":"10.1200\/JCO.20.01307","volume":"38","author":"J Jee","year":"2020","unstructured":"Jee J, Foote MB, Lumish M, Stonestrom AJ, Wills B, Narendra V, et al. Chemotherapy and COVID-19 outcomes in patients with cancer. J Clin Oncol. 2020;38:3538\u201346.","journal-title":"J Clin Oncol"},{"key":"1253_CR4","first-page":"1","volume":"10","author":"H Liu","year":"2020","unstructured":"Liu H, Yang D, Chen X, Sun Z, Zou Y, Chen C, et al. The effect of anticancer treatment on cancer patients with COVID-19: A systematic review and meta-analysis. Cancer Med. 2020;10:1\u201314.","journal-title":"Cancer Med"},{"key":"1253_CR5","doi-asserted-by":"publisher","first-page":"100615","DOI":"10.1016\/j.gore.2020.100615","volume":"33","author":"M Liontos","year":"2020","unstructured":"Liontos M, Kaparelou M, Karofylakis E, Kavatha D, Mentis A, Zagouri F, et al. Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19. Gynecol Oncol Rep. 2020;33:100615.","journal-title":"Gynecol Oncol Rep"},{"key":"1253_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.2169\/internalmedicine.6294-20","volume":"60","author":"K Nagai","year":"2021","unstructured":"Nagai K, Kitamura K, Hirai Y, Nutahara D, Nakamura H, Taira J, et al. Successful and safe reinstitution of chemotherapy for pancreatic cancer after COVID-19. Intern Med. 2021;60:231\u20134.","journal-title":"Intern Med"},{"key":"1253_CR7","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13045-020-00968-1","volume":"13","author":"G Lancman","year":"2020","unstructured":"Lancman G, Mascarenhas J, Bar-Natan M. Severe COVID-19 virus reactivation following treatment for B cell acute lymphoblastic leukemia. J Hematol Oncol. 2020;13:131.","journal-title":"J Hematol Oncol"},{"key":"1253_CR8","doi-asserted-by":"publisher","first-page":"102991","DOI":"10.1016\/j.critrevonc.2020.102991","volume":"152","author":"G Di Lorenzo","year":"2020","unstructured":"Di Lorenzo G, Di Trolio R, Kozlakidis Z, Busto G, Ingenito C, Buonerba L, et al. COVID 19 therapies and anti-cancer drugs: a systematic review of recent literature. Crit Rev Oncol Hematol. 2020;152:102991.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1253_CR9","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/S1470-2045(20)30310-7","volume":"21","author":"K Yang","year":"2020","unstructured":"Yang K, Sheng Y, Huang C, Jin Y, Xiong N, Jiang K, et al. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21:904\u201313.","journal-title":"Lancet Oncol"},{"key":"1253_CR10","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1016\/S0140-6736(20)31173-9","volume":"395","author":"LYW Lee","year":"2020","unstructured":"Lee LYW, Cazier JB, Angelis V, Arnold R, Bisht V, Campton NA, et al. COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. Lancet. 2020;395:1919\u201326.","journal-title":"Lancet"},{"key":"1253_CR11","doi-asserted-by":"publisher","first-page":"100463","DOI":"10.1016\/j.eclinm.2020.100463","volume":"25","author":"YM Zhao","year":"2020","unstructured":"Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, Jia JL, Li LM, Mao HL, Zhou XM, Luo H, et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.","journal-title":"EClinicalMedicine"},{"key":"1253_CR12","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1148\/rg.337130057","volume":"33","author":"SJ Kligerman","year":"2013","unstructured":"Kligerman SJ, Franks TJ, Galvin JR, et al. Organization and fibrosis as a response to lung injury in diffuse alveolar damage, organizing pneumonia, and acute fibrinous and organizing pneumonia. Radiographics. 2013;33:1951\u201375.","journal-title":"Radiographics"},{"key":"1253_CR13","first-page":"11.e0240347","volume":"15","author":"Y Wang","year":"2020","unstructured":"Wang Y, Jin C, Wu CC, Zhao H, Liang T, Liu Z, et al. Organizing pneumonia of COVID-19: time-dependent evolution and outcome in CT findings. PLoS ONE. 2020;15:11.e0240347.","journal-title":"PLoS ONE"},{"key":"1253_CR14","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.annonc.2020.04.475","volume":"31","author":"ML Solodky","year":"2020","unstructured":"Solodky ML, Galvez C, Russias B, Detourbet P, N\u2019Guyen-Bonin V, Herr AL, et al. Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19. Ann Oncol. 2020;31:1087\u20138.","journal-title":"Ann Oncol"},{"key":"1253_CR15","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1016\/S1470-2045(20)30309-0","volume":"21","author":"J Tian","year":"2020","unstructured":"Tian J, Yuan X, Xiao J, Zhong Q, Yang C, Liu B, et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study. Lancet Oncol. 2020;21:893\u2013903.","journal-title":"Lancet Oncol"},{"key":"1253_CR16","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13058-020-01293-8","volume":"22","author":"P Vuagnat","year":"2020","unstructured":"Vuagnat P, Frelaut M, Ramtohul T, Basse C, Diakite S, Noret A, et al. COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area. Breast Cancer Res. 2020;22:55.","journal-title":"Breast Cancer Res"},{"key":"1253_CR17","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1136\/jitc-2020-000952","volume":"8","author":"E Rossi","year":"2020","unstructured":"Rossi E, Schinzari G, Tortora G. Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment. J Immunother Cancer. 2020;8:952.","journal-title":"J Immunother Cancer"},{"key":"1253_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021436","author":"The RECOVERY Collaborative Group","year":"2020","unstructured":"The RECOVERY Collaborative Group. Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report. N Engl J Med. 2020. https:\/\/doi.org\/10.1056\/NEJMoa2021436.","journal-title":"N Engl J Med"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-021-01253-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-021-01253-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-021-01253-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T03:22:52Z","timestamp":1672888972000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-021-01253-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,21]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1253"],"URL":"https:\/\/doi.org\/10.1186\/s40792-021-01253-0","relation":{},"ISSN":["2198-7793"],"issn-type":[{"type":"electronic","value":"2198-7793"}],"subject":[],"published":{"date-parts":[[2021,7,21]]},"assertion":[{"value":"27 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from the patient for this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained from the patient in the case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and\/or animals rights"}},{"value":"Informed consent was obtained from the patient in the case report.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"170"}}